OxyContin
Sacklers accused of personally directing deceptive OxyContin sales tactics
January 17, 2019Sales and Marketing OxyContin, Purdue Pharma, opidois, opioid crisis, pain, sackler
Members of the billionaire Sackler dynasty personally directed efforts to mislead doctors and patients as to the dangers of the …
Alabama’s biggest insurer will no longer cover OxyContin prescriptions
November 9, 2018Medical Communications Alabama, Blue Cross and Blue Shield, OxyContin, insurance, opioids
The state of Alabama’s biggest insurer Blue Cross and Blue Shield will no long cover opioid painkiller OxyContin. The decision …
Purdue-owning Sackler family own second opioid drug maker, FT reveals
September 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OxyContin, Purdue Pharma, opioid, opioid crisis, sackler
The billionaire Sackler family, the owners of OxyContin drugmaker Purdue Pharma, have been revealed to own a second opioid drug …
Top Ten most popular articles on Pharmafile.com this week
August 17, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, CMO, Litigation, OxyContin, Purdue Pharma, approvals, top 10
This week’s pharmaceutical headlines were dominated by legal spats as the state of New York sued OxyContin drug maker Purdue …
New York sues Purdue Pharma over opioid crisis
August 15, 2018Research and Development Litigation, New York, OxyContin, Purude pharma, opioid crisis, state
New York State have sued OxyContin drug maker Purdue Pharma over allegations surrounding widespread fraud and deception in the marketing …
Letters to doctors reduce opioid prescriptions, study shows
August 10, 2018Medical Communications OxyContin, USA, fentanyl, opioid, opioid crisis, research, study
A study has shown that Doctors who received a letter from the medical examiner’s office informing them of their patient’s …
Makers of immediate-release opioids must fund training on their use, FDA says
September 29, 2017Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin
As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …
US city takes drug company to court over opioid crisis
March 16, 2017Medical Communications OxyContin, opioid, opioid crisis
The opioid crisis in North America continues to rumble on, ruining lives and causing untold damage to communities. One city, …
J&J and Purdue settle Kentucky lawsuits for $39.5 million
December 24, 2015Sales and Marketing Johnson and Johnson, Kentucky, OxyContin, Purdue Pharma, Risperdal, lawsuits
Johnson & Johnson and Purdue Pharma have settled separate lawsuits with the US state of Kentucky for a total of …
FDA approves limited OxyContin use in children
August 17, 2015Sales and Marketing FDA, OxyContin, Purdue, Purdue Pharma, oxycodone
The FDA has approved the limited use of the strong painkiller Oxycontin for children in the US aged between 11 …
Latest content
FibroFind appoints Lee Borthwick as CEO
